(UroToday.com) Josias Grogg presented results of a study assessing the diagnostic accuracy of PSMA-PET-CT for pelvic lymph node staging in men with prostate cancer undergoing radical prostatectomy and pelvic lymph node dissection at the European Association of Urology 2021 annual meeting’s metastatic prostate cancer session. In men with newly diagnosed prostate cancer, only limited data describes the diagnostic accuracy of PSMA PET/CT as a staging tool. Most series only compared PSMA PET/CT with conventional imaging but rarely with endpoints including histopathology and clinical follow-up: